Find Grants for Municipalities, Political Subdivisions, and State Governments

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Deadline: May 7, 2026

Opportunity Number: PAR-25-110

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865

View Grant

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Deadline: May 7, 2026

Opportunity Number: PAR-25-111

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.865, 93.855, 93.279, 93.313

View Grant

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027

Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: November 5, 2026

Opportunity Number: PAR-25-255

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.172

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027

Opportunity Number: PAR-25-256

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.172

View Grant

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-273

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.351

View Grant

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Deadline: May 4, 2028

Opportunity Number: PA-25-168

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: May 4, 2028

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859

View Grant

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

Deadline: April 20, 2027

Opportunity Number: RFA-ES-25-002

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: April 20, 2027

Status: Posted

CFDA Numbers: 93.113

View Grant

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-203

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

View Grant

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-202

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

View Grant

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

Deadline: June 22, 2026

Opportunity Number: PAR-25-170

Agency: National Institutes of Health

Open Date: November 13, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.399, 93.853, 93.866

View Grant

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-167

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Deadline: September 7, 2028

Opportunity Number: PA-25-253

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: September 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-027

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

View Grant

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-081

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393, 93.399, 93.394, 93.395

View Grant

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

Deadline: January 7, 2028

Opportunity Number: PAR-25-136

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PA-25-172

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

Deadline: July 9, 2026

Opportunity Number: PAR-25-049

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: July 9, 2026

Status: Posted

CFDA Numbers: 93.853

View Grant

NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-234

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853

View Grant

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-079

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.395, 93.394

View Grant

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: May 7, 2026

Opportunity Number: PAR-25-063

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026

Opportunity Number: PAR-25-153

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.395

View Grant

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Deadline: September 7, 2027

Opportunity Number: PAR-24-325

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394

View Grant

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-145

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

View Grant

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Deadline: May 7, 2026

Opportunity Number: PAR-25-036

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

View Grant